163 related articles for article (PubMed ID: 37794663)
1. Identification of Plasma Biomarkers in Drug-Naïve Schizophrenia Using Targeted Metabolomics.
Su Q; Bi F; Yang S; Yan H; Sun X; Wang J; Qiu Y; Li M; Li S; Li J
Psychiatry Investig; 2023 Sep; 20(9):818-825. PubMed ID: 37794663
[TBL] [Abstract][Full Text] [Related]
2. Alteration of lipids and amino acids in plasma distinguish schizophrenia patients from controls: A targeted metabolomics study.
Liu Y; Song X; Liu X; Pu J; Gui S; Xu S; Tian L; Zhong X; Zhao L; Wang H; Liu L; Xu G; Xie P
Psychiatry Clin Neurosci; 2021 Apr; 75(4):138-144. PubMed ID: 33421228
[TBL] [Abstract][Full Text] [Related]
3. Metabolic profiling identifies phospholipids as potential serum biomarkers for schizophrenia.
Wang D; Cheng SL; Fei Q; Gu H; Raftery D; Cao B; Sun X; Yan J; Zhang C; Wang J
Psychiatry Res; 2019 Feb; 272():18-29. PubMed ID: 30579177
[TBL] [Abstract][Full Text] [Related]
4. Potential plasma biomarker panels identification for the diagnosis of first-episode schizophrenia and monitoring antipsychotic monotherapy with the use of metabolomics analyses.
Song M; Liu Y; Zhou J; Shi H; Su X; Shao M; Yang Y; Wang X; Zhao J; Guo D; Liu Q; Zhang L; Zhang Y; Lv L; Li W
Psychiatry Res; 2023 Mar; 321():115070. PubMed ID: 36706560
[TBL] [Abstract][Full Text] [Related]
5. The relationship between alterations in plasma metabolites and treatment responses in antipsychotic-naïve female patients with schizophrenia.
Wang X; Xie J; Ma H; Li G; Li M; Li S; Sun X; Zhao Y; Sun W; Yang S; Li J
World J Biol Psychiatry; 2024 Feb; 25(2):106-115. PubMed ID: 37867221
[TBL] [Abstract][Full Text] [Related]
6. Peripheral Complement Factor-Based Biomarkers for Patients with First-Episode Schizophrenia.
Cao Y; Xu Y; Xia Q; Shan F; Liang J
Neuropsychiatr Dis Treat; 2023; 19():1455-1462. PubMed ID: 37384352
[TBL] [Abstract][Full Text] [Related]
7. Metabolomics and lipidomics analyses by
Tasic L; Pontes JGM; Carvalho MS; Cruz G; Dal Mas C; Sethi S; Pedrini M; Rizzo LB; Zeni-Graiff M; Asevedo E; Lacerda ALT; Bressan RA; Poppi RJ; Brietzke E; Hayashi MAF
Schizophr Res; 2017 Jul; 185():182-189. PubMed ID: 28040324
[TBL] [Abstract][Full Text] [Related]
8. Plasma metabolomics of schizophrenia with cognitive impairment: A pilot study.
Jiang Y; Sun X; Hu M; Zhang L; Zhao N; Shen Y; Yu S; Huang J; Li H; Yu W
Front Psychiatry; 2022; 13():950602. PubMed ID: 36245866
[TBL] [Abstract][Full Text] [Related]
9. Alterations of eicosanoids and related mediators in patients with schizophrenia.
Wang D; Sun X; Yan J; Ren B; Cao B; Lu Q; Liu Y; Zeng J; Huang N; Xie Q; Gu H; Wang J
J Psychiatr Res; 2018 Jul; 102():168-178. PubMed ID: 29674269
[TBL] [Abstract][Full Text] [Related]
10. Comparison of gut microbiome profile in patients with schizophrenia and healthy controls - A plausible non-invasive biomarker?
Gokulakrishnan K; Nikhil J; Viswanath B; Thirumoorthy C; Narasimhan S; Devarajan B; Joseph E; David AKD; Sharma S; Vasudevan K; Sreeraj VS; Holla B; Shivakumar V; Debnath M; Venkatasubramanian G; Varambally S
J Psychiatr Res; 2023 Jun; 162():140-149. PubMed ID: 37156128
[TBL] [Abstract][Full Text] [Related]
11. Metabolomic Identification of Exosome-Derived Biomarkers for Schizophrenia: A Large Multicenter Study.
Du Y; Chen L; Li XS; Li XL; Xu XD; Tai SB; Yang GL; Tang Q; Liu H; Liu SH; Zhang SY; Cheng Y
Schizophr Bull; 2021 Apr; 47(3):615-623. PubMed ID: 33159208
[TBL] [Abstract][Full Text] [Related]
12. Network Association of Biochemical and Inflammatory Abnormalities With Psychiatric Symptoms in First-Episode Schizophrenia Patients.
Yan J; Chen Y; Ju P; Gao J; Zhang L; Li J; Wang K; Zhang J; Li C; Xia Q; Zhu C; Zhang X
Front Psychiatry; 2022; 13():834539. PubMed ID: 35273531
[TBL] [Abstract][Full Text] [Related]
13. Establishment of an assistive diagnostic model for schizophrenia with oxidative stress biomarkers.
Wang S; Yuan X; Pang L; Song P; Jia R; Song X
Front Pharmacol; 2023; 14():1158254. PubMed ID: 37007024
[No Abstract] [Full Text] [Related]
14. [Establishment of diagnostic model for schizophrenia based on neurotrophic factor and other biomarkers].
Pang LJ; Li X; Yuan XX; Hei GR; Zhang LY; Wang SY; Chen YS; Song PL; Song XQ
Zhonghua Yi Xue Za Zhi; 2023 May; 103(17):1310-1315. PubMed ID: 37150680
[No Abstract] [Full Text] [Related]
15. [Integrated analysis of serum untargeted metabolomics and targeted bile acid metabolomics for identification of diagnostic biomarkers for colorectal cancer].
Wang X; Zhu Y; Zhou H; Huang Z; Chen H; Zhang J; Yang S; Chen G; Zhang Q
Nan Fang Yi Ke Da Xue Xue Bao; 2023 Mar; 43(3):443-453. PubMed ID: 37087590
[TBL] [Abstract][Full Text] [Related]
16. Metabolomics profiling reveals altered lipid metabolism and identifies a panel of lipid metabolites as biomarkers for Parkinson's disease related anxiety disorder.
Dong MX; Hu L; Wei YD; Chen GH
Neurosci Lett; 2021 Feb; 745():135626. PubMed ID: 33440238
[TBL] [Abstract][Full Text] [Related]
17. DNA hypermethylation of serotonin transporter gene promoter in drug naïve patients with schizophrenia.
Abdolmaleky HM; Nohesara S; Ghadirivasfi M; Lambert AW; Ahmadkhaniha H; Ozturk S; Wong CK; Shafa R; Mostafavi A; Thiagalingam S
Schizophr Res; 2014 Feb; 152(2-3):373-80. PubMed ID: 24411530
[TBL] [Abstract][Full Text] [Related]
18. A Metabolomics Study of Serum in Hospitalized Patients With Chronic Schizophrenia.
Okamoto N; Ikenouchi A; Watanabe K; Igata R; Fujii R; Yoshimura R
Front Psychiatry; 2021; 12():763547. PubMed ID: 34975570
[No Abstract] [Full Text] [Related]
19. Peripheral biomarkers allow differential diagnosis between schizophrenia and bipolar disorder.
Tasic L; Larcerda ALT; Pontes JGM; da Costa TBBC; Nani JV; Martins LG; Santos LA; Nunes MFQ; Adelino MPM; Pedrini M; Cordeiro Q; Bachion de Santana F; Poppi RJ; Brietzke E; Hayashi MAF
J Psychiatr Res; 2019 Dec; 119():67-75. PubMed ID: 31568986
[TBL] [Abstract][Full Text] [Related]
20. Potential role between inflammatory cytokines and Tie-2 receptor levels and clinical symptoms in patients with first-episode schizophrenia.
Yan F; Meng X; Cheng X; Pei W; Chen Y; Chen L; Zheng M; Shi L; Zhu C; Zhang X
BMC Psychiatry; 2023 Jul; 23(1):538. PubMed ID: 37491201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
